Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab for Cancer-Related Fatigue
NCT00112749Phase 2Terminated
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Feb 2005
- Primary completion
- Jan 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of infliximab in cancer-related fatigue (CRF), sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Feb 2005; status: terminated.
02
Drugs
infliximab
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT00112749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00112749.